Proteomic biomarkers of sleep apnea
- 12 November 2020
- journal article
- research article
- Published by Oxford University Press (OUP) in Sleep
- Vol. 43 (11)
- https://doi.org/10.1093/sleep/zsaa086
Abstract
Obstructive sleep apnea (OSA) is characterized by recurrent partial to complete upper airway obstructions during sleep, leading to repetitive arousals and oxygen desaturations. Although many OSA biomarkers have been reported individually, only a small subset have been validated through both cross-sectional and intervention studies. Here, we used a highly multiplexed aptamer array (SomaScan) for proteomic analysis of serum samples from 713 individuals in the Stanford Sleep Cohort, a patient-based registry. Outcome measures derived from overnight polysomnography included Obstructive Apnea Hypopnea Index (OAHI), Central Apnea Index (CAI), 2% Oxygen Desaturation index, mean and minimum oxygen saturation indices during sleep. Additionally, a separate intervention-based cohort of 16 individuals was used to assess proteomic profiles pre- and post-intervention with positive airway pressure. After statistical adjustment for age, age of sample, gender and body mass index, OAHI was associated with 65 proteins, predominantly pathways of complement, coagulation, cytokine signaling, and hemostasis which were upregulated. CAI was associated with two proteins including Roundabout homolog 3 (ROBO3), a protein involved in bilateral synchronization of the pre-Bötzinger complex and cystatin F. Analysis of pre- and post- intervention samples were less revealing as only 2 proteins that were differentially associated with active treatment: Insulin-like growth factor-binding protein3 (IGFBP-3) increased while LEAP1 (Hepicidin) decreased with intervention. An OAHI machine learning classifier (OAHI >=15 vs OAHI<15) trained on SomaScan protein measures alone performed robustly, achieving 76% accuracy in a validation dataset. Multiplex protein assays offer diagnostic potential and provide new insights into the biological basis of sleep disordered breathing.Keywords
Funding Information
- Stanford Center for Sleep Sciences and Medicine
- National Institutes of Health (5R01HL071515, K23-NS089922, UL1RR024992, KL2-TR000450)
- Washington University Institute of Clinical and Translational Sciences (UL1TR000448)
- National Center for Advancing Translational Sciences
- Qatar Foundation
This publication has 104 references indexed in Scilit:
- pROC: an open-source package for R and S+ to analyze and compare ROC curvesBMC Bioinformatics, 2011
- Aptamer-Based Multiplexed Proteomic Technology for Biomarker DiscoveryPLOS ONE, 2010
- Prospective Study of Obstructive Sleep Apnea and Incident Coronary Heart Disease and Heart FailureCirculation, 2010
- Obstructive Sleep Apnea–Hypopnea and Incident StrokeAmerican Journal of Respiratory and Critical Care Medicine, 2010
- Sleep-Disordered Breathing and Mortality: A Prospective Cohort StudyPLoS Medicine, 2009
- ToppGene Suite for gene list enrichment analysis and candidate gene prioritizationNucleic Acids Research, 2009
- Increased low-grade inflammation and plasminogen-activator inhibitor-1 level in nondippers with sleep apnea syndromeJournal of Hypertension, 2008
- Cystatin F is a cathepsin C-directed protease inhibitor regulated by proteolysisThe EMBO Journal, 2008
- Statistical significance for genomewide studiesProceedings of the National Academy of Sciences of the United States of America, 2003
- Significance analysis of microarrays applied to the ionizing radiation responseProceedings of the National Academy of Sciences of the United States of America, 2001